Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated No phase listed Observational

An Observational Study of Aducanumab-avwa in Participants With Alzheimer's Disease in the US

ClinicalTrials.gov ID: NCT05097131

Public ClinicalTrials.gov record NCT05097131. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 22, 2026, 4:17 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

International Collaboration for Real-World Evidence in Alzheimer's Disease (ICARE AD)- A Prospective Real-World Observational Study of Aducanumab-avwa in Patients With Alzheimer's Disease in the US

Study identification

NCT ID
NCT05097131
Recruitment status
Terminated
Study type
Observational
Phase
Not listed
Lead sponsor
Biogen
Industry
Enrollment
29 participants

Conditions and interventions

Interventions

Not listed

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 17, 2021
Primary completion
May 19, 2022
Completion
May 19, 2022
Last update posted
Apr 17, 2023

2021 – 2022

United States locations

U.S. sites
22
U.S. states
13
U.S. cities
22
Facility City State ZIP Site status
Research Site Chula Vista California 91910
Mehdi Meratee MD Valencia California 91355
Research Site Boca Raton Florida 33487
Research Site Bradenton Florida 34205
New Life Medical Research Center, Inc Hialeah Florida 33012
Miami Jewish Health System, Inc Miami Florida 33180
Imic, Inc. Palmetto Bay Florida 33157
Neurostudies, Inc Port Charlotte Florida 33952
Vero Beach Neurology and Research Institute Vero Beach Florida 32960
Northwest Neurology Chicago Illinois 60631
Research Site Ozark Missouri 65721
Las Vegas Medical Research Las Vegas Nevada 89128
South Shore Neurologic Associates, P.A. Patchogue New York 11772
Carolina Clinical Research & Consulting, LLC Asheboro North Carolina 27204
Research Site Matthews North Carolina 28105
Research Site Canton Ohio 44718
Dayton Center for Neurological Associates Centerville Ohio 45459
Center for Cognitive Health Portland Oregon 97225
Abington Neurological Associates Abington Pennsylvania 19001
Coastal Neurology, PA Port Royal South Carolina 29935
Genesis Neuroscience Clinic Knoxville Tennessee 37909
The Memory Clinic Bennington Vermont 05201

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05097131, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 17, 2023 · Synced Apr 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05097131 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →